Ambulatory Care
Asenapine
$8.00
Universal Activity Number: 407-000-10-063-H01-P
CEUs 0.1
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 12/01/2010
Expiration date: 12/01/2013
CEUs 0.1
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 12/01/2010
Expiration date: 12/01/2013
Article title:
view more on 407-000-10-063-H01-P
Asenapine: A Novel Atypical Antipsychotic Agent for Schizophrenia and Bipolar I Disorder
Asenapine
$8.00
Universal Activity Number: 407-000-10-063-H01-T
CEUs 0.1
Audience: Pharmacy Technicians
Activity Type: Knowledge-based
Issued date: 12/01/2010
Expiration date: 12/01/2013
CEUs 0.1
Audience: Pharmacy Technicians
Activity Type: Knowledge-based
Issued date: 12/01/2010
Expiration date: 12/01/2013
Article title:
view more on 407-000-10-063-H01-T
Asenapine: A Novel Atypical Antipsychotic Agent for Schizophrenia and Bipolar I Disorder
Overview of Chemotherapy
$8.00
Universal Activity Number: 407-000-10-065-H01-T
CEUs 0.1
Audience: Pharmacy Technicians
Activity Type: Knowledge-based
Issued date: 12/01/2010
Expiration date: 12/01/2013
CEUs 0.1
Audience: Pharmacy Technicians
Activity Type: Knowledge-based
Issued date: 12/01/2010
Expiration date: 12/01/2013
Article title:
view more on 407-000-10-065-H01-T
Overview of Chemotherapy and Nine Commonly Prescribed Chemotherapeutic Medications
Heart Failure in the Elderly
$10.00
Universal Activity Number: 407-000-10-024-H01-P
CEUs 0.1
Audience: Pharmacist
Activity Type: Application-based
Issued date: 10/01/2010
Expiration date: 10/01/2013
CEUs 0.1
Audience: Pharmacist
Activity Type: Application-based
Issued date: 10/01/2010
Expiration date: 10/01/2013
Article title:
view more on 407-000-10-024-H01-P
Treatment of Systolic Heart Failure in the Elderly: An Evidence-Based Review
Limited evidence exists for determining safe and effective treatment plans for heart failure in the elderly. Since the majority of heart failure patients are elderly, pharmacists are often required to use clinical judgment to make medication recommendations. This article outlines the available literature for each treatment option in this population and serves as a concise review of systolic heart failure. The knowledge gained prepares pharmacists to make safe and evidence-based treatment recommendations.
Mitiglinide
$10.00
Universal Activity Number: 407-000-10-025-H01-P
CEUs 0.1
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 10/01/2010
Expiration date: 10/01/2013
CEUs 0.1
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 10/01/2010
Expiration date: 10/01/2013
Article title:
view more on 407-000-10-025-H01-P
Mitiglinide: A Novel Agent for the Treatment of Type 2 Diabetes Mellitus
Mitiglinide, a new meglitinide agent for prandial control of diabetes is currently in clinical trials. While highlighting relevant clinical properties, the article places emphasis on those properties that distinguish mitiglinide from other agents. Where might mitiglinide fit into the standard diabetes therapy? This article reviews the available literature and prepares pharmacists to decide the future role of mitiglinide.